Anavex Life Sciences
AVXL
127 hedge funds and large institutions have $493M invested in Anavex Life Sciences in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 17 closing their positions.
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
81% more capital invested
Capital invested by funds: $272M → $493M (+$220M)
65% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 26
18% more funds holding
Funds holding: 108 → 127 (+19)
3.53% more ownership
Funds ownership: 26.23% → 29.76% (+3.5%)
0% more call options, than puts
Call options by funds: $34.9M | Put options by funds: $34.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$19.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.71M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.77M |
| 4 |
Morgan Stanley
New York
|
+$2.76M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$7.8M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$2.68M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.44M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.79M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.6M |
AVXL Hedge Fund Activity: Q2 2021 in Review
127 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2021, worth a combined $493M — up 81% from $272M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new AVXL positions and 17 closed out — a net gain of 19 holders — while 43 added to existing stakes and 26 trimmed.
The largest buyer was State Street, adding an estimated $19.6M. The largest seller was Invesco, cutting an estimated $7.8M.
- 127 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2021, up from 108 in Q1 2021.
- Funds reported $493M of Anavex Life Sciences stock for Q2 2021, up 81% quarter-over-quarter.
- 36 funds opened new Anavex Life Sciences positions in Q2 2021 and 17 closed out, a net change of +19 holders.
- The largest Anavex Life Sciences buyer in Q2 2021 was State Street, an estimated $19.6M added.
- The largest Anavex Life Sciences seller in Q2 2021 was Invesco, an estimated $7.8M sold.
Based on aggregated 13F filings for Q2 2021.